Read + Share
Delany-Moretlwe S, Hughes JP, Bock P, Ouma SG, et al. Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase
3, randomised clinical trial. Lancet 2022 Apr 1. pii: S0140-6736(22)00538.
PMID: 35378077
|
 |
|
Delany-Moretlwe S, Hughes JP, Bock P, Ouma SG, et al. Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase
3, randomised clinical trial. Lancet 2022 Apr 1. pii: S0140-6736(22)00538.
PMID: 35378077
|
|
|
|